Quarantini LC

Universidade Federal da Bahia, Programa de Pós-Graduação em Medicina e Saúde (PPGMS), Laboratory of Neuropsychopharmacology (LANP), Salvador, BA, Brazil.

7 papers

ArticleKetamine

Health-related quality of life after ketamine or esketamine treatment for chronic pain: a review of randomized controlled trials.

Figueiredo AV, Garcia SL, Araújo IL +2

Europe PMC2026
ArticleKetamine

Measuring suicidal behavior in the era of rapid-acting antidepressants: A systematic review of ketamine studies.

Vieira F, Caliman-Fontes AT, Souza-Marques B +5

Europe PMC2025
ArticleKetamine

Arketamine: a scoping review of its use in humans.

Leal GC, Lima-Araújo I, Roiter DG +5

Europe PMC2025
ArticleKetamine

Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence.

Caliman-Fontes AT, Vieira F, Leal GC +7

Europe PMC2024
ArticleKetamine

Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.

Alves-Pereira R, Fontes M, Cordeiro V +7

Europe PMC2024
ArticleKetamine

Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.

Echegaray MVF, Mello RP, Magnavita GM +16

Europe PMC2025
ArticleKetamine

Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.

Caliman-Fontes AT, Leal GC, Correia-Melo FS +17

Europe PMC2023